Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Anti-factor Xa compounds disclosed by RPR

Feb. 14, 1997

ZymoGenetics/Novo Nordisk isolate anticlotting agent

Feb. 14, 1997

FDA approves product for hemophilia

Feb. 13, 1997

Roberts receives approvable letter from FDA for Agrylin

Feb. 12, 1997

Potent gpIIb/IIIa antagonist synthesized using combinatorial techniques

Feb. 11, 1997

NIH funds development of antiplatelet agents from Cypress/PRP

Feb. 7, 1997

BASF discloses antithrombotic from ticks

Feb. 6, 1997

COR Therapeutics' cardiovascular drug candidate enters phase I trials

Feb. 5, 1997

DuPont Merck reports new fibrinogen antagonists

Jan. 31, 1997

New anticoagulant drug candidates from Berlex

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...